GlassScriptPhysician profile
Brandon S Claflin
NPI 1376684167
$922.05
in general payments reported to CMS, 2019-2025
9 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.12 · 2020: $46.74 · 2022: $359 · 2023: $47.80 · 2024: $155 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $239.71 | 2022 | |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $108.52 | 2023-2025 | Qutenza |
| Spr Therapeutics, INC | $103.86 | 2022 | |
| Boston Scientific Corporation | $91.78 | 2024-2025 | General - Therapies, Varithena Administration Pack |
| Abbott Laboratories | $74.28 | 2020-2025 | Proclaim |
| Pfizer INC. | $25.72 | 2020 | |
| Pacira Therapeutics, INC. | $23.12 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Claflin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.